Scientists in Germany develop a new analytical method that enables improved insight into (mRNA) nanoparticles, and similar pharmaceutical and non-pharmaceutical products

Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved COVID-19 vaccine, was recently recognised by the Nobel Prize in Medicine or Physiology. But mRNA’s potential for pharmaceutical application is expected to go much beyond this – it could open up new opportunities for the treatment and prevention of […]

continue reading